{"id":774778,"date":"2022-03-28T20:00:04","date_gmt":"2022-03-28T18:00:04","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical\/"},"modified":"2023-07-11T14:17:03","modified_gmt":"2023-07-11T12:17:03","slug":"eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/","title":{"rendered":"Eckuity Moves to Disrupt Manufacturing in the $300 Billion Biologics Market with an Investment in Mobius Biomedical"},"content":{"rendered":"NEW YORK--(BUSINESS WIRE)--New York- and London-based HealthTech venture firm Eckuity has invested in Mobius Biomedical, a development-stage company designing disruptive new technology and processes for lower cost, next-generation biologics manufacturing.\n\n\n\nDespite their prevalence and importance to human health, the production of biologics continues to employ predominantly legacy processes and equipment that have fundamentally not changed for decades, resulting in costs of $500M-$1B and 3-4 years in order to build and bring a new production facility online. Estimates indicate that the current global production capacity accounts for less than half of potential demand and the biologics market is projected to grow by 10% yearly over the next
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–New York- and London-based HealthTech venture firm Eckuity has invested in Mobius Biomedical, a development-stage company designing disruptive new technology and processes for lower cost, next-generation biologics manufacturing. Despite their prevalence and importance to human health, the production of biologics continues to employ predominantly legacy processes and equipment that have fundamentally not changed […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-774778","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"\nEckuity Moves to Disrupt Manufacturing in the $300 Billion Biologics Market with an Investment in Mobius Biomedical - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eckuity Moves to Disrupt Manufacturing in the $300 Billion Biologics Market with an Investment in Mobius Biomedical - BeBeez\" \/>\n<meta property=\"og:description\" content=\"NEW YORK--(BUSINESS WIRE)--New York- and London-based HealthTech venture firm Eckuity has invested in Mobius Biomedical, a development-stage company designing disruptive new technology and processes for lower cost, next-generation biologics manufacturing. Despite their prevalence and importance to human health, the production of biologics continues to employ predominantly legacy processes and equipment that have fundamentally not changed […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-28T18:00:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-11T12:17:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"olomaster\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"olomaster\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/\"},\"author\":{\"name\":\"olomaster\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\"},\"headline\":\"Eckuity Moves to Disrupt Manufacturing in the $300 Billion Biologics Market with an Investment in Mobius Biomedical\",\"datePublished\":\"2022-03-28T18:00:04+00:00\",\"dateModified\":\"2023-07-11T12:17:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/\"},\"wordCount\":472,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/\",\"name\":\"Eckuity Moves to Disrupt Manufacturing in the $300 Billion Biologics Market with an Investment in Mobius Biomedical - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-03-28T18:00:04+00:00\",\"dateModified\":\"2023-07-11T12:17:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eckuity Moves to Disrupt Manufacturing in the $300 Billion Biologics Market with an Investment in Mobius Biomedical\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\",\"name\":\"olomaster\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"caption\":\"olomaster\"},\"url\":\"https:\/\/bebeez.it\/en\/author\/olomaster\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eckuity Moves to Disrupt Manufacturing in the $300 Billion Biologics Market with an Investment in Mobius Biomedical - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/","og_locale":"en_US","og_type":"article","og_title":"Eckuity Moves to Disrupt Manufacturing in the $300 Billion Biologics Market with an Investment in Mobius Biomedical - BeBeez","og_description":"NEW YORK--(BUSINESS WIRE)--New York- and London-based HealthTech venture firm Eckuity has invested in Mobius Biomedical, a development-stage company designing disruptive new technology and processes for lower cost, next-generation biologics manufacturing. Despite their prevalence and importance to human health, the production of biologics continues to employ predominantly legacy processes and equipment that have fundamentally not changed […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/","og_site_name":"BeBeez","article_published_time":"2022-03-28T18:00:04+00:00","article_modified_time":"2023-07-11T12:17:03+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"author":"olomaster","twitter_card":"summary_large_image","twitter_misc":{"Written by":"olomaster","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/"},"author":{"name":"olomaster","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518"},"headline":"Eckuity Moves to Disrupt Manufacturing in the $300 Billion Biologics Market with an Investment in Mobius Biomedical","datePublished":"2022-03-28T18:00:04+00:00","dateModified":"2023-07-11T12:17:03+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/"},"wordCount":472,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/","name":"Eckuity Moves to Disrupt Manufacturing in the $300 Billion Biologics Market with an Investment in Mobius Biomedical - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-03-28T18:00:04+00:00","dateModified":"2023-07-11T12:17:03+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Eckuity Moves to Disrupt Manufacturing in the $300 Billion Biologics Market with an Investment in Mobius Biomedical"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518","name":"olomaster","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","caption":"olomaster"},"url":"https:\/\/bebeez.it\/en\/author\/olomaster\/"}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/774778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=774778"}],"version-history":[{"count":1,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/774778\/revisions"}],"predecessor-version":[{"id":888132,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/774778\/revisions\/888132"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=774778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=774778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=774778"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=774778"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=774778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}